MME and acute lymphoblastic leukemia: The reported incidence of aberrant antigens ranges from 25 to 55%.6,15 Among T-ALL cases, we found CD117 and HLA-DR as the most common myeloid aberrant markers and CD10 as B-cell aberrant expression.